23
Participants
Start Date
February 13, 2018
Primary Completion Date
February 19, 2025
Study Completion Date
February 19, 2025
Laboratory Biomarker Analysis
Correlative studies
Pharmacological Study
Correlative studies
Quality-of-Life Assessment
Ancillary studies
Recombinant EphB4-HSA Fusion Protein
Given IV
Johns Hopkins University, Baltimore
Grady Health System, Atlanta
University of Miami, Miami
John H. Stroger Jr., Hospital of Cook County, Chicago
Washington University, St Louis
UCLA CARE Center, Los Angeles
UC San Diego Moores Cancer Center, La Jolla
UCSD Moores Cancer Center, La Jolla
Virginia Mason Medical Center, Seattle
National Cancer Institute (NCI)
NIH
Vasgene Therapeutics, Inc
INDUSTRY
The Emmes Company, LLC
INDUSTRY
University of Arkansas
OTHER
AIDS Malignancy Consortium
NETWORK